Group Versus Traditional Prenatal Care for Diabetes
Status: | Recruiting |
---|---|
Conditions: | Women's Studies, Diabetes |
Therapuetic Areas: | Endocrinology, Reproductive |
Healthy: | No |
Age Range: | 14 - 50 |
Updated: | 3/21/2019 |
Start Date: | September 14, 2017 |
End Date: | September 10, 2021 |
Contact: | Ebony B Carter, MD, MPH |
Email: | cartere@wudosis.wustl.edu |
Phone: | 314-362-8280 |
Group Versus Traditional Prenatal Care for Diabetes: A Randomized Controlled Trial
The investigators primary objective is to conduct a randomized trial to determine the effect
of diabetes group prenatal care on glycemic control and postpartum weight retention in women
with type 2 diabetes and gestational diabetes.
of diabetes group prenatal care on glycemic control and postpartum weight retention in women
with type 2 diabetes and gestational diabetes.
Long term, the investigator aims to test the central hypothesis that group prenatal care,
compared to traditional prenatal care, will improve, 1.) glycemic control and, 2.) postpartum
weight retention in women with type 2 and gestational diabetes. The objective of this
proposal is to conduct a randomized trial in two phases to determine the effect of Diabetes
Group Care (GC) on glycemic control in pregnant women with T2DM and GDM (Antepartum Phase)
and the impact on postpartum weight retention (Postpartum Phase).
compared to traditional prenatal care, will improve, 1.) glycemic control and, 2.) postpartum
weight retention in women with type 2 and gestational diabetes. The objective of this
proposal is to conduct a randomized trial in two phases to determine the effect of Diabetes
Group Care (GC) on glycemic control in pregnant women with T2DM and GDM (Antepartum Phase)
and the impact on postpartum weight retention (Postpartum Phase).
Inclusion Criteria:
1. English speaking
2. Type 2 diabetes OR gestational diabetes diagnosed by 2-step method(1) OR likely
pre-existing Type 2 diabetes with one of the following during pregnancy and < 34
weeks:
1. 1 hour glucose challenge test > 185mg/dL OR
2. A1c > 6.5% OR
3. Fasting plasma glucose > 126mg/dL (2)
3. Ability to attend group prenatal visit at specified days and times
4. Willingness to be randomized at 22 weeks 0 days-34 weeks 0 days OR initial visit
between 24 weeks 0 days-34 weeks 0 days
5. Ability to give informed consent
Exclusion Criteria:
1. Prior participation in diabetes group care
2. Type 1 Diabetes
3. Multiple gestation
4. Major fetal anomaly
5. Serious medical co-morbidity necessitating more care than can be safely provided in
group setting, as deemed by medical provider.
6. Serious psychiatric illness including schizophrenia necessitating more care than can
safely be provided in group setting, as deemed by medical provider.
We found this trial at
1
site
Click here to add this to my saved trials